OAG - OPEN-ANGLE GLAUCOMA
Clinical trials for OAG - OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new OAG - OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for OAG - OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drop combo aims to lower pressure in glaucoma patients
Disease control Recruiting nowThis study tests a new preservative-free eye drop combination (QLS-111-FDC) to lower eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 adults with mild to moderate disease will receive the treatment. The goal is to see if it safely reduces eye press…
Matched conditions: OAG - OPEN-ANGLE GLAUCOMA
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device aims to tackle glaucoma while fixing cataracts
Disease control Recruiting nowThis early study tests a new surgical tool that opens up the eye's natural drainage channels to lower pressure in people with open-angle glaucoma who are also having cataract surgery. About 70 participants will receive the device during their cataract procedure. The main goal is …
Matched conditions: OAG - OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: New World Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC